Management of Wet Age-Related Macular Degeneration in Spain: Challenges for Treat and Extend Implementation in Routine Clinical Practice
Autor: | A. García-Layana, J. García-Arumí, M. S. Figueroa, L. Arias Barquet, J. M. Ruíz-Moreno, L. Monclús-Arbona, null The Spanish AMD Multicenter Group |
---|---|
Přispěvatelé: | [García-Layana A] Clínica Universidad de Navarra, Pamplona, Spain. [García-Arumí J] Servei d’ Oftalmologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Figueroa MS] Vissum Madrid, Madrid, Spain. [Arias Barquet L] Hospital de Bellvitge, L'Hospitalet de Llobregat, Spain. [Ruíz-Moreno JM] Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain. [Monclús-Arbona L] Bayer Hispania, S.L., Sant Joan Despí, Spain, Vall d'Hebron Barcelona Hospital Campus, UAM. Departamento de Cirugía |
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Delphi method
Two-round study questionnaire Therapeutics::Clinical Protocols [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT] 0302 clinical medicine Retina specialists experienced lcsh:Ophthalmology Health care Equips d'especialistes - Espanya Duration (project management) Degeneració (Patologia) Aflibercept Proactive treatment patterns Standard treatment Degeneration (Pathology) Retinal diseases Geographic Locations::Europe::Spain [GEOGRAPHICALS] Malalties de la retina Ciencias de la información::análisis de sistemas::técnica Delfos [CIENCIA DE LA INFORMACIÓN] Information Science::Systems Analysis::Delphi Technique [INFORMATION SCIENCE] Ubicaciones Geográficas::Europa (Continente)::España [DENOMINACIONES GEOGRÁFICAS] Medical emergency Protocols clínics medicine.drug Research Article Article Subject Medicina wAMD) MEDLINE Retina specialists terapéutica::protocolos clínicos [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS] 03 medical and health sciences oftalmopatías::enfermedades de la retina::degeneración retiniana::degeneración macular::degeneración macular exudativa [ENFERMEDADES] Eye Diseases::Retinal Diseases::Retinal Degeneration::Macular Degeneration::Wet Macular Degeneration [DISEASES] Ranibizumab medicine Dosing Espanya business.industry Macular degeneration medicine.disease Ophthalmology Spain lcsh:RE1-994 030221 ophthalmology & optometry Anti-VEGF administration business 030217 neurology & neurosurgery Degeneració macular |
Zdroj: | Scientia Journal of Ophthalmology, Vol 2019 (2019) Dadun. Depósito Académico Digital de la Universidad de Navarra instname Dipòsit Digital de la UB Universidad de Barcelona Journal of Ophthalmology Biblos-e Archivo. Repositorio Institucional de la UAM Biblos-e Archivo: Repositorio Institucional de la UAM Universidad Autónoma de Madrid |
ISSN: | 2090-004X |
DOI: | 10.1155/2019/9821509 |
Popis: | Purpose. To ascertain wet AMD (wAMD) management patterns in Spain. Methods. A two-round Delphi study conducted through a questionnaire-based survey designed from literature review and validated by an independent Steering Committee. Results. Forty-nine retina specialists experienced in wAMD participated by answering the two-round study questionnaire. Retina specialists are the main responsible for wAMD diagnosis and monitoring, including visits and associated procedures, with a median time per visit of 15 minutes. Standard treatment strategies are based on anti-VEGF administration, including standard loading dose administration followed by maintenance with aflibercept or ranibizumab (81% of patients). Although treat and extend (T&E) dosing strategy is considered as optimal for wAMD management (78% of the panelists), the main routine healthcare limitations (i.e., visits overload, reduced staff, short visit time, coordination issues, lack of facilities) conduct to self-defined “flexible” strategies, based on T&E and pro-re-nata (PRN) protocols. Conclusion. Proactive treatment patterns (T&E) are the preferred ones by the retina specialists in Spain. However, their proper implementation is difficult due to healthcare resource limitations, as well as organisation and logistic issues. .e use of anti-VEGF agents with longer duration of action could facilitate the use of strict T&E approaches according to routine clinical practices The study has been sponsored by Bayer Hispania S.L. Logistics |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |